CFO Lars Sandström to leave Sobi
(Thomson Reuters ONE) -
CFO Lars Sandström will leave Sobi during the summer 2012 to return to his
former employer Scania. The recruitment of a new CFO has been initiated.
Lars Sandström joined Sobi in 2010 and was appointed CFO in February 2011.
"We thank Lars for his contributions to Sobi and wish him well in his future
endeavors, says Geoffrey McDonough, President and CEO of Sobi.
For further information, please contact:
Åsa Stenqvist, Head of Communications
Tel.: +46 8 697 21 88
Swedish Orphan Biovitrum (Sobi)
Sobi is a leading integrated biopharmaceutical company dedicated to bringing
innovative therapies and services to improve the health of rare disease patients
and their families. The product portfolio comprises about 45 marketed products
as well as projects in the late clinical phase. Key therapeutic areas are
Inflammation and Genetics & Metabolism. In 2011, Sobi had revenues of SEK 1.9
billion and around 500 employees. The share (STO: SOBI) is listed on NASDAQ OMX
Stockholm. More information is available at www.sobi.com.
The information above has been published pursuant to the Swedish Securities
Market Act and/or the Financial Instruments Trading Act. The information was
released for public distribution on 20 March, 2012 at 12.15 CET.
Sobi press release March 20, 2011 in pdf format:
http://hugin.info/134557/R/1595703/502536.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
[HUG#1595703]
Unternehmensinformation / Kurzprofil:
" alt="SilverCrest Reports 58m @ 164.7 gpt Ag Eq* at La Joya Extends Main Mineralized Trend 500 metres NW">
Datum: 20.03.2012 - 12:16 Uhr
Sprache: Deutsch
News-ID 126639
Anzahl Zeichen: 2123
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 146 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CFO Lars Sandström to leave Sobi"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
